Argon Medical to start Cleaner15 technology for mechanical thrombectomy procedures Furthering its commitment to advancing the treatment of patients identified as having ESRD , Argon Medical Products, Inc. We are excited to present this leading-edge addition to the Cleaner line of products, commented George A . Leondis , President of Argon. The 0.044 wire combined with the increase in torque supplies the physician with the power necessary for difficult declot cases resulting in reduced procedure time, along with enhanced steerability in tight aneurysms and stenoses.P., Conshohocken, PA). Personally i think very comfortable using the device in all applications including stents and venous valves without risk of binding, stated Dr.

When blood flow was disrupted to a small area deep in the back part of her human brain relatively, she lost numerous brain functions. Many of these disabilities were related to vision, that was not unexpected, since one of the brain functions localized to the section of the brain may be the processing of visible information. Fortunately, within a few days of the stroke, the visible problems had opted away. But a fresh symptom emerged: The patient stopped dreaming. Such lack of dreaming–along with visual disturbances- – following harm to a specific part of the brain goes by the name Charcot-Wilbrand syndrome, called for the eminent neurologists Jean-Martin Hermann and Charcot Wilbrand, who first defined it in the 1880s. Related StoriesGDF10 molecule defined as a key player in fix mechanisms after strokeAdvances in whole mount brain imaging: an interview with Patrick Myles, President, Huron Digital PathologyLiposomal sizing and the Coulter theory: an interview with Professor Melvin E.